New Treatment Approaches for Hypertension and Diabetes

Article Figures & Data

Figures

  • Figure 1.

    Elevated Systolic BP in Type 2 Diabetes Increases Cardiovascular Risk.

    Stamler J et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434–44.
  • Figure 2.

    Observed Mean Change in Systolic BP.

    BAT=baroreflex activation therapy.Bisognano JD et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension. J Am Coll Cardiol. 2011;58(7):765–73.
  • Figure 3.

    Primary Endpoint: 6-Month Office BP.

    Reproduced with permission from The Lancet; Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. 2010;376(9756):1903–9.